To determine whether this mechanism was specific to anti-CTLA4 or shared with other checkpoint inhibitors, mice were treated with anti-PD1, RT or the combination, which resulted in tumor cure only in mice treated with the combination (Fig. 2e). This evidence concerns the gene CTLA4 and neoplasm.